Personalis, Inc. Fair Value Adjustment of Warrants
Personalis, Inc. (PSNL) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-02-26
- Personalis, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- Personalis, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Personalis, Inc. fair value adjustment of warrants for the quarter ending 2024-12-31 was $0.00.
- Personalis, Inc. fair value adjustment of warrants for the quarter ending 2024-09-30 was $26.01M.
- Personalis, Inc. fair value adjustment of warrants for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Personalis, Inc. fair value adjustment of warrants for fiscal 2024 was $18.27M, a 353.79% increase from fiscal 2023.
- Personalis, Inc. fair value adjustment of warrants for fiscal 2023 was $4.03M.
- Personalis, Inc. fair value adjustment of warrants for fiscal 2019 was $1.40M, a 258.82% increase from fiscal 2018.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.01M derived: sum of 2 quarters · filed 2026-02-26 | $18.27M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $26.01M 10-Q · filed 2025-11-04 | $18.27M 10-Q · filed 2025-11-04 | ||
| 2023-12-31 | $4.03M 10-K · filed 2025-02-27 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $1.27M derived: sum of 3 quarters · filed 2022-02-24 | $1.40M 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.27M derived: sum of 2 quarters · filed 2020-11-05 | $1.40M 10-Q · filed 2020-11-05 | $1.63M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.40M 10-Q · filed 2020-08-06 | $1.63M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2019-03-31 | $134.00K 10-Q · filed 2020-05-07 | $359.00K derived: sum of 2 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $391.00K 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $166.00K 10-Q · filed 2019-11-13 | |||
| 2017-12-31 | $64.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |